PHARMACOVIGILANCE COURSE MCQS – Fineness Institute

Skip to content

Home
About Us
COURSES ONLINE
STUDENT SPEAKS
RECENT RECOGNITION
Corporate Training
Blog
Gallery
Contact Us

Menu

Home
About Us
COURSES ONLINE
STUDENT SPEAKS
RECENT RECOGNITION
Corporate Training
Blog
Gallery
Contact Us

PHARMACOVIGILANCE COURSE MCQS

Fineness institute of clinical research

Welcome to your PHARMACOVIGILANCE COURSE MCQS

Name

Email

Contact No.

THE SCIENCE AND ACTIVITIES RELATING TO THE DETECTION, ASSESSMENT, UNDERSTANDING AND PREVENTION OF ADVERSE EFFECTS OR ANY OTHER DRUG-RELATED PROBLEMS.

a) Clinical research

b) Clinical data management

c) Pharmacovigilance

d) Project management

None

PHARMACOVIGILANCE CONTINUE THROUGHOUT :-

a) Post marketing survelliance

b) Pre and post marketing survelliance

c) Pre marketing survelliance

d) None of the above

None

PROCESS OF PHARMACOVIGILANCE IS-

a) Case processing-signal management-risk management -submission to umc

b) Case processing-risk management -signal management-submission to umc

c) Submission to umc- case processing-signal management-risk management

d) Risk management- submission to umc- case processing-signal management

None

ADVERSE EVENT IS DUE TO –

a) Life threatening

b) Due to drug/treatment

c) May or may not have casual relationship with treatment

d) None of above

None

SERIOUS ADVERSE EVENT

a) Result in death

b) Life threatening

c) Both a and b

d) None of the above

None

PHARMACOVIGILANCE

a) Increase economic burden on heathcare system

b) Improve public health

c) Neglects patient safety

d) Discourage effective drug use

None

COWPOX VACCINATION STARTED IN-

a) 1748

b) 1818

c) 1848

d) 1718

None

SULFANILAMIDE DISASTER OCCURRED IN

a) 1938

b) 1948

c) 1958

d) 1948

None

NDA STANDS FOR –

a) New drug applicant

b) Novel drug application

c) New device application

d) New drug application

None

PHARMACOVIGILANCE PROGRAMME OF INDIA

a) 2009

b) 2010

c) 2005

d) 2012

None

Time’s up

Fineness institute of clinical research believes in bringing premium programs at a nominal cost making it accessible to aspirants across the country.

Subscribe, Like & Follow Us on

Facebook Linkedin Youtube Instagram

© 2023 All Rights Reserved Fineness Institute Of Clinical Research | Developed by : Evolix Technology